Takeda Bid To DQ Baker Botts 'Spurious At Best,' Judge Says
A New Jersey federal judge isn't buying Takeda Pharmaceutical Co.'s argument that it believes it is entitled to attorney-client privilege from Baker Botts after the law firm represented the drugmaker's co-plaintiff...To view the full article, register now.
Already a subscriber? Click here to view full article